Skip to content

Orphan Drugs At BioPharma Mexico 2014

August 27, 2014

The 2nd Annual BioPharma Mexico conference, November 4 – 5, 2014, in Mexico City, brings together COFEPRIS, payers, government, biopharma, academia, and other stakeholders to talk about strategies to bring biocomparables, stem cells, and orphan drugs to market faster.

No orphan drugs are currently manufactured in Mexico nonetheless, orphan diseases have gained more recognition in the health and pharma communities. Despite the limited number of patients for a particular drug, this market is on the rise in Mexico.

Victor M. Anaya Bourgoing, General Director of Genzyme Mexico and Raul Vivar, Country Medical Head of Shire Mexico, will both be speaking on the state of orphan drugs at this year’s BioPharma Mexico.

Topics on orphan drugs in Mexico to be discussed include:

•   Understanding where COFEPRIS stands on regulation

•   Do’s and don’ts of importing orphan drugs

•   Accessing rare disease patients

•   Recent Orphan Drug Act in Mexico

•   Raising awareness of orphan diseases.

A compiled list of the top 20 trends in the Mexican pharma industry, from regulation to market access, is available as an eBook to download. The eBook includes segments on orphan drugs, patient groups, and awareness of orphan diseases.

Download the eBook.

To join or find out more about the event, visit the event website.

Meeting Logo courtesy of BioPharma Mexico 2014. The Orphan Druganaut Blog is a Media Partner.

Copyright © 2012-2014, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: